Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 2/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | THRB | P10828 | 1/20 | 0.32 |
| ▸ | RECQL | P46063 | 1/20 | 0.32 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.30 |
| ▸ | TP53 | P04637 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL951508 | 0.87 | — | — | |
| SCHEMBL5194168 | 0.87 | GRIN2D (0.30) | — | |
| SCHEMBL950259 | 0.87 | ALDH1A1 (0.33) | TSHRALDH1A1 | |
| SCHEMBL28392656 | 0.85 | — | — | |
| SCHEMBL952341 | 0.81 | ALDH1A1 (0.37) | TSHRALDH1A1SOAT1CYP2C19 | |
| SCHEMBL8002717 | 0.81 | — | — | |
| SCHEMBL5434607 | 0.80 | SMN1; SMN2 (0.32) | SMN1; SMN2TSHRALDH1A1THRBRECQL | |
| SCHEMBL9305160 | 0.79 | CYP2C19 (0.31) | ALDH1A1CYP2C19 | |
| SCHEMBL949443 | 0.79 | TRPA1 (0.46) | ALDH1A1CYP2C19 | |
| SCHEMBL14744178 | 0.78 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 73 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119505178-B | Cured product of organic phosphine modified unsaturated resin and polyhalogenated compound and preparation method thereof | 浙江工业大学 | 2025-04-04 | — | — | CN | claimed |
| CN-119505178-A | Cured product of organic phosphine modified unsaturated resin and polyhalogenated compound and preparation method thereof | 浙江工业大学 | 2025-02-25 | — | — | CN | claimed |
| CN-118653302-B | Preparation method of long-acting antibacterial cellulose material | 北京林业大学 | 2024-11-15 | — | — | CN | claimed |
| CN-118653302-A | Preparation method of long-acting antibacterial cellulose material | 北京林业大学 | 2024-09-17 | — | — | CN | claimed |
| CN-117624613-A | Degradable phosphorus/silicon composite antibacterial/flame-retardant material and preparation method thereof | 浙江工业大学 | 2024-03-01 | — | — | CN | claimed |
| EP-3041885-B1 | METHOD FOR SEQUENTIALLY SYNTHESISING POLY(ALKOXYAMINE AMIDE)S, COPOLYMERS OBTAINED AND USES THEREOF | CENTRE NATIONAL DE LA RECHERCHE SCIENT (ETABLISSEMENT PUBLIC À CARACTÈRE SCIENT CULTUREL ET PROFESSI (FR) | 2018-01-03 | — | — | EP | claimed |
| US-20160222162-A1 | METHOD FOR SEQUENTIALLY SYNTHESISING POLY(ALKOXYAMINE AMIDE)S, COPOLYMERS OBTAINED AND USES THEREOF | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2016-08-04 | — | — | US | claimed |
| US-20250235434-A1 | RIFABUTIN ANALOGS FOR THE TREATMENT OF DISEASE | BioVersys AG (CH) | 2025-07-24 | — | — | US | disclosed |
| CN-120051373-A | Laminate and method for producing laminate | 日东电工株式会社 | 2025-05-27 | — | — | CN | disclosed |
| CN-119505178-B | Cured product of organic phosphine modified unsaturated resin and polyhalogenated compound and preparation method thereof | 浙江工业大学 | 2025-04-04 | — | — | CN | disclosed |
| CN-119724695-A | Insulated wire, method of manufacturing the same, coil, and electronic apparatus | 奇美实业股份有限公司 | 2025-03-28 | — | — | CN | disclosed |
| CN-119708768-A | Polymer film and method for producing same | 奇美实业股份有限公司 | 2025-03-28 | — | — | CN | disclosed |
| CN-119505178-A | Cured product of organic phosphine modified unsaturated resin and polyhalogenated compound and preparation method thereof | 浙江工业大学 | 2025-02-25 | — | — | CN | disclosed |
| US-20130030212-A1 | COMPOUND HAVING ALICYCLIC STRUCTURE, (METH)ACRYLIC ACID ESTER, AND PROCESS FOR PRODUCTION OF THE (METH)ACRYLIC ACID ESTER | IDEMITSU KOSAN CO., LTD. (JP) | 2013-01-31 | — | — | US | disclosed |
| US-20130023693-A1 | COMPOUND HAVING ALICYCLIC STRUCTURE, (METH)ACRYLIC ACID ESTER, AND PROCESS FOR PRODUCTION OF THE (METH)ACRYLIC ACID ESTER | IDEMITSU KOSAN CO., LTD. (JP) | 2013-01-24 | — | — | US | disclosed |
| WO-2011021398-A1 | SUGAR DERIVATIVE HAVING A POLYMERIZABLE GROUP, AND RESIST MATERIAL USING SAID SUGAR DERIVATIVE | 出光興産株式会社 (JP) | 2011-02-24 | — | — | WO | disclosed |
| US-20110009661-A1 | COMPOUND HAVING ALICYCLIC STRUCTURE, (METH)ACRYLIC ACID ESTER, AND PROCESS FOR PRODUCTION OF THE (METH)ACRYLIC ACID ESTER | IDEMITSU KOSAN CO., LTD. (JP) | 2011-01-13 | — | — | US | disclosed |
| EP-0262393-B1 | DERIVATIVES OF ARYLOXYCARBONIC ACIDS, THEIR PREPARATION AND THEIR USE | SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) | 1993-01-07 | — | — | EP | disclosed |
| EP-0262393-A1 | Derivatives of aryloxycarbonic acids, their preparation and their use | SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) | 1988-04-06 | — | — | EP | disclosed |
| US-4192871-A | ANAESTHETICS - STEROIDS | GLAXO LABORATORIES LIMITED (GB) | 1980-03-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130030212-A1 | COMPOUND HAVING ALICYCLIC STRUCTURE, (METH)ACRYLIC ACID ESTER, AND PROCESS FOR PRODUCTION OF THE (METH)ACRYLIC ACID ESTER | ALAD, MMAB, MAT1A | SMN1; SMN2 2540/4885TSHR 2845/4885ALDH1A1 313/4885 |
| US-20130023693-A1 | COMPOUND HAVING ALICYCLIC STRUCTURE, (METH)ACRYLIC ACID ESTER, AND PROCESS FOR PRODUCTION OF THE (METH)ACRYLIC ACID ESTER | ALAD, MMAB, MAT1A | SMN1; SMN2 2540/4885TSHR 2845/4885ALDH1A1 313/4885 |
| US-20250235434-A1 | RIFABUTIN ANALOGS FOR THE TREATMENT OF DISEASE | RIF1, FNTB, Q6ZSR9 | SMN1; SMN2 2556/4885TSHR 2787/4885ALDH1A1 1724/4885 |
| US-20110009661-A1 | COMPOUND HAVING ALICYCLIC STRUCTURE, (METH)ACRYLIC ACID ESTER, AND PROCESS FOR PRODUCTION OF THE (METH)ACRYLIC ACID ESTER | ALAD, MMAB, MAT1A | SMN1; SMN2 2540/4885TSHR 2845/4885ALDH1A1 313/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.